Zafirlukast reduces bronchospasm by blocking IgE from activating mast cells in patients with severe allergic asthma.
Correct Answer:
Verified
Q35: _ is the most common chronic disease
Q36: Agents that are most effective for long-term
Q37: Asthma that occurs two times or less
Q38: The primary cause of COPD includes which
Q39: Patients with COPD who require a sympathomimetic
Q41: The pharmacologic agent _ is recommended for
Q42: Describe the clinical presentation of a patient
Q43: The major causative factor in chronic bronchitis
Q44: Emphysemic patients exhale through _ to maintain
Q45: The primary cause of COPD is _.
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents